Clinical Trial Update: Levetiracetam Treatment of Tardive Dyskinesia [Phase 3]

View source ↗

Summary

Phase 3 trial of levetiracetam for tardive dyskinesia completed; sponsor Yale University.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tardive Dyskinesia

Drugs mentioned

• LEVETIRACETAM (levetiracetam)

Snippet

Sponsor: Yale University | Conditions: Tardive Dyskinesia | Phase 3 | Status: COMPLETED